- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00857935
A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse
March 6, 2009 updated by: ParaPRO LLC
A Pilot Study to Test the Operational Elements of an Actual Use Study Designed to Compare the Safety and Efficacy of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months of Age or Older With Pediculosis Capitis
A pilot study to compare the safety and efficacy of NatrOVA Creme Rinse 1% to NIX Creme Rinse in subjects with Pediculosis Capitis
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A Phase 2b, randomized, single-site, investigator/evaluator blind, two-arm, parallel-group pilot study that tested the operational elements of an "Actual Use" study designed to evaluate the safety and efficacy of a 10-minute treatment and no-nit combing regimen of NatrOVA Creme Rinse 1% versus NIX Creme Rinse in subjects with at least a mild case of head lice.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46240
- Concentrics Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female, 6 months of age or older
- Subject must have a head lice infestation present at baseline
- Subject/caregiver must read English or Spanish at a 7th grade level
- Subject must have an appropriately signed Informed Consent agreement
- Other members of the household with a lice infestation must be willing to be enrolled in the study or treat their infestations with a standard treatment
- Subject agreement to not use any other form of lice treatment during the course of the study
- Subject agreement to not cut or chemically treat their hair in the period between baseline and final, post-treatment visits
Exclusion Criteria:
- Individuals with a history of irritation or sensitivity to pediculicides or hair care products
- Individuals with any visible skin/scalp condition at the treatment site that could interfere with the evaluation
- Individuals previously treated with a pediculicide or any other head lice treatment product within 48 hours prior to enrollment
- Individuals receiving systemic or topical drugs that may interfere with the study results
- Individuals who have participated in a clinical trial within 30 days of enrollment
- Individuals with family members who are infested with lice but are unwilling or unable to enroll in the study or to use the standard course of lice treatment
- Females who are pregnant or nursing
- Sexually-active females not using effective contraception
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
NatrOVA Creme Rinse - 1%
|
NatrOVA Creme Rinse, one or two, 10-minute topical treatments (7 days apart)
|
Active Comparator: 2
NIX Creme Rinse
|
NIX Creme Rinse: one or two, 10-minute topical treatments (7 days apart)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Efficacy of NatrOVA Creme Rinse-1% versus NIX Creme rinse, based on the presence or absence of live lice 14 days after the final treatment.
Time Frame: 14 days after last treatment
|
14 days after last treatment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Safety comparison between NatrOVA Creme Rinse-1% and NIX Creme Rinse, based on the occurrence of adverse events and any increase of scalp and/or ocular irritation, post-treatment.
Time Frame: 14 days after last treatment
|
14 days after last treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mark Moore, MD, Concentrics Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2007
Primary Completion (Actual)
April 1, 2007
Study Completion (Actual)
April 1, 2007
Study Registration Dates
First Submitted
March 5, 2009
First Submitted That Met QC Criteria
March 6, 2009
First Posted (Estimate)
March 9, 2009
Study Record Updates
Last Update Posted (Estimate)
March 9, 2009
Last Update Submitted That Met QC Criteria
March 6, 2009
Last Verified
March 1, 2009
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SPN-203-07
- Concentrics 71007
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head Lice
-
Taro Pharmaceuticals USACompletedLice; Head LiceUnited States
-
Topaz Pharmaceuticals IncCompletedPediculus Humanus Capitis (Head Lice)United States
-
Perrigo CSCIRecruiting
-
Dr. Reddy's Laboratories LimitedCompleted
-
Dr. Reddy's Laboratories LimitedTKL Research, Inc.; AccelovanceCompletedHead LiceUnited States
-
Topaz Pharmaceuticals IncCompleted
-
Infectopharm Arzneimittel GmbHRecruitingPediculosis Capitis | Head Lice Infestation | LiceGermany
-
Dr. Reddy's Laboratories LimitedSyneos Health; AccelovanceCompletedHead Lice InfestationUnited States
-
Alliance PharmaceuticalsSouth Florida Family Health and Research CentersRecruitingHead Lice | Lice Infestations | Pediculosis CapitisUnited States
-
Perrigo CSCIRecruitingHead Lice InfestationMauritius
Clinical Trials on NatrOVA Creme Rinse - 1%
-
ParaPRO LLCCompleted
-
ParaPRO LLCCompletedPediculosis Capitis (Head Lice)United States
-
ParaPRO LLCCompleted
-
ParaPRO LLCCompletedPediculosis Capitis (Head Lice)United States
-
South Florida Family Health and Research CentersCompleted
-
Alliance PharmaceuticalsSouth Florida Family Health and Research CentersRecruitingHead Lice | Lice Infestations | Pediculosis CapitisUnited States
-
ParaPRO LLCCompleted
-
Taro Pharmaceuticals USACompleted
-
ParaPRO LLCCompletedPediculus Capitis InfestationUnited States
-
University of BernNot yet recruiting